Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 9, 2011, Pages 1039-1044

  Dall, Michael ^a,b   Schaffalitzky De Muckadell, Ove B ^b   Møller Hansen, Jane ^b   Wildner Christensen, Mette ^b   Touborg Lassen, Annmarie ^b   Hallas, Jesper ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Complicated peptic ulcer; Helicobacter pylori; Selective serotonin reuptake inhibitor; Serious upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG EXPOSURE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

AGED; CASE-CONTROL STUDIES; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIC ULCER; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 80051767242     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.580100     Document Type: Article

References (35)

1. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009;7:1314-21.
2. de Abajo FJ, Garcia Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: a population-based case-control study. Br Med J 1999;319:1106-9. (Pubitemid 29494721)
3. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001;323:655-8. (Pubitemid 32897004)
4. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003;163: 59-64. (Pubitemid 36091601)
5. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 2005;22: 175-81. (Pubitemid 41153059)
6. Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007; 63:403-8. (Pubitemid 46399132)
7. Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 2008;66:76-81. (Pubitemid 351822152)
8. Lewis JD, Strom BL, Localio AR, Metz DC, Farrar JT, Weinrieb RM, et al. Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf 2008;17:328-35. (Pubitemid 351566348)
9. de Abajo FJ, García-Rodríguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65: 795-803. (Pubitemid 351957705)
10. Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009;104:1475-82.
11. Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8:517-23. (Pubitemid 28023394)
12. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12-16. (Pubitemid 26021814)
13. Javors MA, Houston JP, Tekell JL, Brannan SK, Frazer A. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuro-psychopharmacol 2000;3:229-35.
14. Jaspersen D. Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995;27:622-5.
15. Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9-13. (Pubitemid 34119189)
16. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999;116:1305-9. (Pubitemid 29258878)
17. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359: 14-22. (Pubitemid 34119190)
18. Wildner-Christensen M, Møller Hansen J, Schaffalitzky de Muckadell OB. Rates of dyspepsia one year after Helicobac-ter pylori screening and eradication in a Danish population. Gastroenterology 2003;125:372-9. (Pubitemid 36929417)
19. Gaist D, Sørensen HT, Hallas J. The Danish Prescription Registries. Dan Med Bull 1997;44:445-8 (Pubitemid 27382061)
20. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs and guidelines for ATC classification and DDD assignment. Oslo: Norwegian Institute of Public Health, 2006.
21. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9. (Pubitemid 30185417)
22. Rosholm J-U, Andersen M, Gram LF. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 2001;56:923-9. (Pubitemid 33788571)
23. Rogge J, Wagner D, Carrico R, Glowinski EA, Mahoney SJ, Boguslaski RC, et al. Evaluation of a new urease reagent strip for detection of Helicobacter pylori in gastric biopsy specimens. Am J Gastroenterol 1995;90:1965-8.
24. Lassen AT. Helicobacter pylori eradication in management of dyspepsia. Ph.D. Thesis. Faculty of Health Science, University of Southern Denmark, 2000.
25. Schrier WH, Schoengold RJ, Baker JT, Norell JL, Jaseph CL, Okin Y, et al. Development of FlexSure HP-an immunochromatographic method to detect antibodies against Helicobacter pylori. Clin Chem 1998; 44:293-8. (Pubitemid 28087727)
26. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645-6. (Pubitemid 30422662)
27. Release 10.1. StataCorp, 4905 Lakeway Drive, College Station, Texas 77845 USA. http://www.stata.com.
28. Vestergård A, Bredahl K, Schaffalitzky de Muckadell OB, Pedersen OB, Hansen JM. Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid. Ugeskr Laeger 2009;171:235-9.
29. van Leeuwen AW, de Nooijer P, Hop WC. Screening for cervical carcinoma. Cancer 2005;105:270-6.
30. Reubsaet A, van Osch LA, de Vries H, de Coul MR, Lechner L. Some signals cannot wait: effects of a national campaign on early detection of cancer among Dutch adults (>55 years). Cancer Epidemiol 2009;33:194-200.
31. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Childhood living conditions and Helico-bacter pylori seropositivity in adult life. Lancet 1992;339: 896-7.
32. Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002;31:624-31. (Pubitemid 34732776)
33. Vergara M, Catalán M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005; 21:1411-18. (Pubitemid 40874157)
34. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-600.
35. You JH, Lau W, Lee IY, Yung M, Ching JY, Chan FK, et al. Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis. Int J Clin Pharmacol Ther 2006;44:149-53.